معرفی
Sophie Lehn is an Associate Researcher and Researcher at Lund University Cancer Centre (LUCC), affiliated with the Division of Translational Cancer Research and Experimental Oncology. Her work contributes to the UN Sustainable Development Goals, particularly in cancer research and health innovation.
Research Focus: Dr. Lehn specializes in molecular oncology with emphasis on breast cancer mechanisms, tumor microenvironment interactions, and prognostic biomarkers. Her interdisciplinary approach integrates biochemistry, genetics, and clinical oncology to study:
- Breast cancer metastasis and immunosuppression pathways
- Growth factor signaling in tumor progression
- Multi-omics analysis of cancer subtypes
- Prognostic biomarker discovery across multiple cancers
Publications: Her research output trends toward molecular oncology, with recent work exploring breast cancer immunosuppression (2025), tumor microenvironment dynamics (2018), and cancer subtype classification via multi-omics integration (2016). Recurring themes include biomarker discovery and translational applications.
Academic Leadership: Dr. Lehn actively organizes conferences and workshops, including:
- LUCC Breast and Imaging & Nuclear/Radiology Retreat (2025)
- LUCC Breast research meetings (2023-2024)
- 6th Swedish Cancer Research Meeting (2023)
